Zdrowie i gospodarka · 19/10/2022
FDA Amends Pulmonary-Allergy Drugs Advisory Committee Meeting Notice
The FDA is updating the meeting details of the Pulmonary-Allergy Drugs Advisory Committee, originally announced on September 8, 2022, to reflect changes in the meeting schedule and supplementary information, following the submission of new information for review.
Source: Federal Register — Food and Drug AdministrationOpen original release →